Phase I Study of HXN6005 in Adult Healthy Participants

NCT07449741 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers (HV)

Interventions

DRUG: HXN6005
DRUG: Placebo

Sponsor

Helixon Biotechnology (Suzhou) Co., Ltd